]]> What are the challenges to developing more convenient, oral-based biologics? Credit: Shutterstock.
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.
Over the past few decades, the rise of biologics has been nothing short of meteoric. Between 2010 and 2017, around a quarter of the new molecular entities approved by the US Food and Drug Administration (FDA) fell into this bracket (63 out of a total of 262). That may not sound like a lot, but since biologics are much more expensive than small molecule drugs, they account for most of the worlds top-selling drugs by revenues. They also represent one of the fastest growing categories in pharma.
Unfortunately, biologics have a major downside when it comes to delivery. Unlike small molecule drugs, which can generally be taken orally, biologics are large, complex entities that degrade rapidly in the gastrointestinal tract. Weighing between 200 and 1,000 times the size of a small molecule drug, they almost always need to be delivered via injection or infusion. This is far less convenient than swallowing a pill, not to mention far more costly.
To take diabetes management as an example, most people with diabetes still rely on multiple daily injections. Inhalable insulin has been tried out (as per Exubera in 2006 and Afrezza in 2014) but both suffered with safety concerns and poor sales volume. Oral insulin the holy grail of diabetes treatment has yet to hit the market.
There are dozens of groups around the world intent on creating oral delivery methods. Some focus on modifying the drugs chemical structure to improve their stability in the body. Others focus on the epithelial barrier in the gut if you can make that more permeable, large molecules will be able to pass through more easily.
To give an example of the first approach, researchers at EFPL in Switzerland are working on a method to deliver peptides orally. In 2018, the team developed double bridged peptides a structure with much more stability than a typical amino acid chain. Unfortunately, despite this added stability, most of them still disintegrated in the digestive tract.
Since then, the researchers have found a way to trawl through a peptide library (billions of random peptide sequences, twisted into the double bridged format) to identify the ones that actually are stable. After they have isolated the surviving candidates, they do further tests to find the ones that bind to the disease target.
Its a bit like searching for a needle in a haystack, and this method makes this easy, said Professor Christian Heinis, the lead researcher.
An example of the latter approach comes from Israeli biotech Chiasma. Its Transient Permeability Enhancer (TPE) aims to protect drug molecules from digestive enzymes, as well as triggering the temporary expansion of tight spaces in that gut barrier.
This gives just enough space for the drug molecule to pass into the bloodstream, but not enough space for viruses and bacteria. Last year, the company completed a phase III trial on oral capsules called Mycapssa, which could be used as a maintenance treatment for acromegaly.
There are also a number of oral delivery approaches involving nanoparticles. As the thinking goes: if you incorporate the drug into tiny transporting particles, those particles will be able to protect it from stomach acid, as well as accurately targeting its delivery.
Researchers at Houston Methodist Research Institute in Texas are trialling one such approach, in which a peptide-based drug is chemically linked to fatty acids, and packaged in a nanoparticle. In mouse studies, the animals absorbed almost a quarter of the drug dosage (a lot, considering the typical oral bioavailability for a biologic stands at around 1%).
We know the human body can absorb fatty acids, so we decided to chemically link biological drug molecules to fatty acids to see how well these drugs are absorbed into the gastrointestinal system. It turns out that our transporter approach was effective, saidDr Haifa Shen, Professor of Nanomedicine at Houston Methodist.
Nanotechnology could have many further applications within drug delivery. In particular, it could be used for delivering drugs across the blood-brain barrier, a network of blood vessels that functions a bit like neurological armour. While this barrier protects the brain from harmful chemicals, it also prevents therapeutic agents from getting through.
Researchers at Cedars-Sinai Medical Center in California are working on a new type of nano-immunotherapy, which could deliver cancer drugs directly into brain tumours. Again, they are at an early stage of research, but mouse studies have shown promising results.
Current clinically proven methods of brain cancer immunotherapy do not ensure that therapeutic drugs cross the blood-brain barrier, said Dr Julia Ljubimova, Professor of Neurosurgery and Biomedical Sciences at Cedars-Sinai. Although our findings were not made in humans, they bring us closer to developing a treatment that might effectively attack brain tumours with systematic drug administration.
Another exciting research avenue is microneedles. The promise is clear a minimally invasive, painless technique that could deliver the drug through the skin.
One example is a smart, adhesive insulin-delivery patch, being developed by bioengineers at UCLA. The patch, which is adhesive and resembles a sticking plaster, is pre-loaded with insulin and releases the medicine once blood sugar levels exceed a certain threshold. The technology has been accepted into the FDAs Emerging Technology Program, and human trials could start within the next few years.
US biotech Rani Therapeutics is combining both approaches microneedles and oral biologics delivery with its so-called robotic pill. This capsule, which could be used to deliver a number of biologics, moves through the stomach intact, before reaching the desired location in the gut. Here, it releases biodegradable microneedles, which inject the biologic.
This delivery system is still at an early stage of development, but in preclinical tests it performed as well as a subcutaneous injection. The company also has one human trial to its name a phase I trial for a drug called octreotide, which is normally injected intravenously.
While these research groups, and many others, are seeing promising results in the lab and early trials, it remains to be seen which new delivery methods will become a clinical reality. Given the challenges associated with existing delivery methods, and the seemingly unstoppable rise of biologics, there is everything to play for.
Go here to see the original:
- $700 Million Worth of Synthetic Bitcoin Is Circulating on the Ethereum Blockchain - Bitcoin News - September 8th, 2020
- Exclusive mining could have negative implications for the Blockchain industry, say experts - Cointelegraph - September 8th, 2020
- Reimagining blockchain for healthcare solutions with the MAXathon - Health Europa - September 8th, 2020
- All fintech companies will use blockchain within 10 years: Aussie government report - Cointelegraph - September 8th, 2020
- 'Decentralized Reddit' enables users to secure Twitter on the blockchain - Cointelegraph - September 8th, 2020
- Former Georgian PM: Blockchain is the steam engine of Industry 4.0 - Cointelegraph - September 8th, 2020
- How will decentralized blockchain technology evolve in the future? - Gary Skentelbery - September 8th, 2020
- How the Bitcoin Blockchain Is Being Used to Safeguard Nuclear Power Stations - CoinDesk - CoinDesk - September 8th, 2020
- Starbucks' Deployment of a Blockchain Network May Show Restaurants the Way to Future Revenue Growth | - Restaurant Technology News - September 8th, 2020
- Nanomedicine Market 2020 Global Share, Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis And Forecast To 2026 |... - September 5th, 2020
- Healthcare Nanotechnology (Nanomedicine) Market : Updates, Future Growth, Industry Analysis And Comprehensive Study On Key Players To 2020 2028 -... - September 5th, 2020
- Nanomedicine Market Segmentation By Qualitative And Quantitative Research Incorporating Impact Of Economic And Non-Economic Aspects By 2027 - Reports... - September 5th, 2020
- Impressive Trends and Future Scope of Nanocapsules Market - StartupNG - September 5th, 2020
- NanoViricides is Developing Drugs Against SARS-CoV-2 with an Integrated Approach to Combat COVID-19, as Reported at The LD 500 Virtual Conference -... - September 5th, 2020
- Clene Nanomedicine, researching the use of gold atoms to slow ALS progression, nets $42.5M Series D - Endpoints News - September 2nd, 2020
- Amorphous Soft Magnetic Materials Market to Reach USD 728.5 Million by 2027; Need to Blend Amorphous & Nano-crystalline Alloys will Favor Growth,... - September 2nd, 2020
- 5 Recent Tech Innovations Disrupting the Medical and Healthcare Industry - HealthTechZone - September 2nd, 2020
- Mohali INST scientists develop new nano-particle-based treatment for kala azar - The Tribune India - August 21st, 2020
- Book Review: What Can India's Embrace of Nanotech Tell Us About India's Science? - The Wire Science - August 21st, 2020
- Healthcare Nanotechnology (Nanomedicine) Market Analysis, Key Players, Industry Segments And Forecast To 2026 - The News Brok - August 21st, 2020
- Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region - Good Night, Good Hockey - August 21st, 2020
- New 'molecular computers' find the right cells - UW Medicine Newsroom - August 21st, 2020
- How can nanomedicine be applied to cannabis? - Leafly - August 10th, 2020
- Global Healthcare Nanotechnology (Nanomedicine) Industry Outlook 2020-2027 with Profiles of 46 Players Including Abbott Labs, Celgene Corp, GE... - August 10th, 2020
- Global Projection 2020: Nanomedicine Market Exclusive Profitable Comprehensive Research Report with COVID-19 Impact Overview | Forecast 2029 - News... - August 10th, 2020
- Green One-Step Synthesis of Medical Nanoagents for Advanced Radiation | NSA - Dove Medical Press - August 10th, 2020
- Nanomedicine - Wikipedia - August 10th, 2020
- What is Nanomedicine? : Center for Nanomedicine - August 10th, 2020
- Nanomedicine | medicine | Britannica - August 10th, 2020
- Nanomedicine - an overview | ScienceDirect Topics - August 10th, 2020
- Cleaning the Nano-Texture Glass on Your New iMac - The Mac Observer - August 10th, 2020
- COVID-19 was created in the Wuhan laboratory and is now in the hands of the Chinese military - Malaysian Christian News - August 10th, 2020
- Nanomedicine Market To Reach USD 343.8 Billion By 2026 | CAGR of 12.6% - PharmiWeb.com - August 8th, 2020
- Nanomedicine Market Actual Strategies of Key Players to Overcome COVID 19 Pendamic | GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck... - August 5th, 2020
- What happens when bacteria resist treatment? Trobix lands $3M to protect us from next 'Super Bug' - Geektime - August 5th, 2020
- Topical nanoparticles interfering with the DNA-LL37 complex to alleviate psoriatic inflammation in mice and monkeys - Science Advances - August 5th, 2020
- Global Healthcare Nanotechnology (Nanomedicine) Market Worth $475B by 2027 - Therapeutics Will Account for $369B - Benzinga - August 5th, 2020
- Global Nanotechnology in Medical Market 2020 Comprehensive analysis with Top Trends, Size, Share, Future Growth Opportunities & Forecast by 2027... - August 2nd, 2020
- Researchers uncover how cells interact with supporting proteins to heal wounds | The Source - Washington University in St. Louis Newsroom - August 2nd, 2020
- Nanomedicine Market Provides in-depth analysis of the Nanomedicine Industry, with current trends and future estimations to elucidate the investment... - July 31st, 2020
- Global Nano Therapy Market- Industry Analysis and Forecast (2020-2027)-by, Type, Application, and Region. - Red & Black Student Newspaper - July 31st, 2020
- Nanomedical Market 2019 | How The Industry Will Witness Substantial Growth In The Upcoming Years | Exclusive Report By MRE Bulletin Line - Bulletin... - July 31st, 2020
- BIOPHARMACEUTICAL AND BIOMEDICINE MARKET RESEARCH, OPPORTUNITIES, EMERGING TRENDS, COMPETITIVE STRATEGIES AND FORECASTS 2016-2028 | AMGEN INC., F.... - July 31st, 2020
- Redefining the status quo in healthcare - The Business Times - July 31st, 2020
- Nanomedicine Market Report (2019-2027) | The demand for the Market will drastically increase in the Future? - Research Newspaper - July 31st, 2020
- Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy - DocWire News - July 29th, 2020
- New insights into wound healing - Newswise - July 29th, 2020
- Seer raises another $55M and finally reveals proteomic tech can it hold up? - Endpoints News - July 29th, 2020
- Tracked the behavior of nanoparticles in the body - FREE NEWS - July 29th, 2020
- CLR 131 Leads a New Generation of Lipid-Based Cancer Drug Delivery Systems - OncLive - July 24th, 2020
- Nanomedicine Market 2019 by Rising-Trends, Growth Analysis, Industry Share, Product Types, User-Demand, Business Strategy and Comprehensive Valuation... - July 24th, 2020
- Nanomedicine Market Competitive Research And Precise Outlook 2020 To 2026 - Cole of Duty - July 24th, 2020
- Global Nanotechnology in Medical Market is Expected to Grow at Moderate Pace by 2027 Post COVID 19 Pandemic, Latest Market Research Report by... - July 24th, 2020
- Small AI biotech BioXcel surges on positive PhIII results, setting up dementia and Alzheimer's test - Endpoints News - July 24th, 2020
- NanoViricides to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit Today, July 21, 2020 - BioSpace - July 22nd, 2020
- Investigating the Effect of Nano-Curcumin on the Expression of Biofilm | IDR - Dove Medical Press - July 20th, 2020
- Coronavirus news: Understanding the relationship between nanotechnology and COVID-19 - Free Press Journal - July 19th, 2020
- Healthcare Nanotechnology (Nanomedicine) Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And... - July 19th, 2020
- THE 1918 PANDEMIC: What Happened When the Flu Overwhelmed Humboldt's Medical System? - Lost Coast Outpost - July 19th, 2020
- Nanomedicine Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To 2026 - 3rd Watch... - July 19th, 2020
- Nanomedicine Market 2020 Industry Share, Size, Consumption, Growth, Top Manufacturers, Type and Forecast to 2028 Bulletin Line - Bulletin Line - July 19th, 2020
- Nanomedicine Market 2020 Recent Industry Developments and Growth Strategies Adopted by Top Key Players Worldwide and Assessment to 2025 Bulletin Line... - July 18th, 2020
- What is nanomedicine? | ETPN - July 18th, 2020
- Nanosensors Market to Remain Balanced During the the COVID-19 Period - Cole of Duty - July 18th, 2020
- Nanomedicine Market 2020 Industry Share, Size, Consumption, Growth, Top Manufacturers, Type and Forecast to 2028 - Bulletin Line - July 18th, 2020
- New Comprehensive Report on Nanomedicine Market to Witness an Outstanding Growth during 2020 2025 with Top Players Like - Jewish Life News - July 14th, 2020
- Healthcare Nanotechnology Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To 2026 -... - July 14th, 2020
- Report: New PET radiotracer proven safe and effective in imaging malignant brain tumors - Tdnews - July 13th, 2020
- Value of Healthcare Nanotechnology (Nanomedicine) Market Predicted to Surpass US$ by the of 2075 2015 2021 - Bulletin Line - July 13th, 2020
- Potential Impact of COVID-19 on Research report explores the Healthcare Nanotechnology (Nanomedicine) Market for the forecast period, 2020-2026 -... - July 12th, 2020
- New nanomedicines for mRNA therapeutics in breast cancer and heart failure - Mirage News - July 12th, 2020
- New Comprehensive Report on Antibacterial Nano Coatings Market to Witness an Outstanding Growth during 2020 2025 with Top Players Like Nanogate AG,... - July 12th, 2020
- Nanomedicine Market with Emerging Trends, Global Scope and Demand 2020 to 2026 - The Canton Independent Sentinel - July 11th, 2020
- 3D Printed Medicine Uses Fish Gelatin to Deliver Cancer Treatment - 3DPrint.com - July 11th, 2020
- INBRAIN Neuroelectronics receives funding to push forward the development of graphene-based implants for brain disorders - Graphene-Info - June 14th, 2020
- Nanotechnology for Healthcare Market Global Competitions and Business Outlook 2020 to 2026 - News Collective - June 14th, 2020
- Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prod | DDDT - Dove Medical Press - June 14th, 2020
- Medical Biomimetics - Market Research | Recent Trends and Growth Forecast 2025 - CueReport - June 14th, 2020
- 'Laser tweezers' in nano lab used in search for drug to prevent COVID-19 replication - The Province - May 3rd, 2020
- Missouri Indian American Professor Develops Disinfecting Tunnel to Kill Viral Infections Using Silver Nano-particles - India West - May 3rd, 2020